ResearchMoz added Latest Research Report titled " Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2014 " to it's Large Report database.
Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2014
Summary
Global Markets Directs, Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2014, provides an overview of the Retinitis Pigmentosa s therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Retinitis Pigmentosa (Retinitis), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Retinitis Pigmentosa (Retinitis) and special features on late-stage and discontinued projects.
Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=195741
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Read All Healthcare Market Research Reports @ http://www.researchmoz.us/healthcare-market-reports-56.html
Table of Contents
Table of Contents 2
List of Tables 7
List of Figures 8
Introduction 9
Global Markets Direct Report Coverage 9
Retinitis Pigmentosa (Retinitis) Overview 10
Therapeutics Development 11
Pipeline Products for Retinitis Pigmentosa (Retinitis) Overview 11
Pipeline Products for Retinitis Pigmentosa (Retinitis) Comparative Analysis 12
Retinitis Pigmentosa (Retinitis) Therapeutics under Development by Companies 13
Retinitis Pigmentosa (Retinitis) Therapeutics under Investigation by Universities/Institutes 16
Retinitis Pigmentosa (Retinitis) Pipeline Products Glance 18
Late Stage Products 18
Clinical Stage Products 19
Early Stage Products 20
Retinitis Pigmentosa (Retinitis) Products under Development by Companies 21
Retinitis Pigmentosa (Retinitis) Products under Investigation by Universities/Institutes 23
Retinitis Pigmentosa (Retinitis) Companies Involved in Therapeutics Development 24
QLT Inc. 24
Sanofi 25
Sun Pharmaceutical Industries Limited 26
BioDiem Ltd 27
ReGenX Biosciences, LLC 28
ReNeuron Group plc 29
R-Tech Ueno, Ltd. 30
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket
Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2014
Summary
Global Markets Directs, Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2014, provides an overview of the Retinitis Pigmentosa s therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Retinitis Pigmentosa (Retinitis), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Retinitis Pigmentosa (Retinitis) and special features on late-stage and discontinued projects.
Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=195741
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Read All Healthcare Market Research Reports @ http://www.researchmoz.us/healthcare-market-reports-56.html
Table of Contents
Table of Contents 2
List of Tables 7
List of Figures 8
Introduction 9
Global Markets Direct Report Coverage 9
Retinitis Pigmentosa (Retinitis) Overview 10
Therapeutics Development 11
Pipeline Products for Retinitis Pigmentosa (Retinitis) Overview 11
Pipeline Products for Retinitis Pigmentosa (Retinitis) Comparative Analysis 12
Retinitis Pigmentosa (Retinitis) Therapeutics under Development by Companies 13
Retinitis Pigmentosa (Retinitis) Therapeutics under Investigation by Universities/Institutes 16
Retinitis Pigmentosa (Retinitis) Pipeline Products Glance 18
Late Stage Products 18
Clinical Stage Products 19
Early Stage Products 20
Retinitis Pigmentosa (Retinitis) Products under Development by Companies 21
Retinitis Pigmentosa (Retinitis) Products under Investigation by Universities/Institutes 23
Retinitis Pigmentosa (Retinitis) Companies Involved in Therapeutics Development 24
QLT Inc. 24
Sanofi 25
Sun Pharmaceutical Industries Limited 26
BioDiem Ltd 27
ReGenX Biosciences, LLC 28
ReNeuron Group plc 29
R-Tech Ueno, Ltd. 30
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket
Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
No comments:
Post a Comment